SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Vion (formerly Oncorx) interesting play on Gene Therapy

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jim Oravetz who wrote (172)1/17/2000 9:22:00 PM
From: Jim Oravetz  Read Replies (1) of 370
 
The other drug: Triapine, which is designed to prevent the replication of tumor cells by blocking a critical step in the synthesis of DNA --> HIV

Also found this PR at the vionphama.com site

Patent Office Grants Vion's Request for Interference with Biochem Pharma's Patent
Claiming use of 3TC in Treating Hepatitis B

- Vion Receives Senior Party Status in Patent Interference -

NEW HAVEN, Conn., Nov. 29 /PRNewswire/ -- Vion Pharmaceuticals, Inc. (Nasdaq: VION) today announced that it has obtained a ruling from the United States Patent and Trademark Office, Board of Patent Appeals and Interferences, granting Vion's request for an Interference between a Vion-licensed patent application from Yale University and United States patent No. 5,532,246 assigned to BioChem Pharma, Inc. Both the patent application and the BioChem Pharma patent claim the right to the use of 3TC, also known as lamivudine and Epivir(TM), to treat hepatitis B virus ("HBV"). Vion believes that the BioChem Pharma patent involved in this Interference is licensed to Glaxo Group.snip...

This is interesting because BCHE is just starting to ramp up lamivudine production and is on track to get $$$ from all the millions of people in SE Asia who have HB.

Jim
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext